Cyclic AMP and cyclic GMP phosphodiesterases: Target for drug development
- 1 January 1988
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 12 (2) , 85-92
- https://doi.org/10.1002/ddr.430120203
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Mechanism of the positive inotropic effect of milrinone in cultured embryonic chick ventricular cells*Journal of Molecular and Cellular Cardiology, 1987
- Selective inhibitors of three forms of cyclic nucleotide phosphodiesterasesTrends in Pharmacological Sciences, 1984
- Responses to Amrinone in Isolated Cardiac Muscles from Cat, Rabbit, and Guinea PigJournal of Cardiovascular Pharmacology, 1984
- Effects of vinpocetine on cyclic nucleotide metabolism in vascular smooth muscleBiochemical Pharmacology, 1984
- Cardiotonic Activity of Milrinone, a New and Potent Cardiac Bipyridine, on the Normal and Failing Heart of Experimental AnimalsJournal of Cardiovascular Pharmacology, 1983
- Identification and properties of cyclic nucleotide phosphodiesterasesMolecular and Cellular Endocrinology, 1982
- Biochemical Studies on the Mechanism of Cardiotonic Activity of MDL 17,043Journal of Cardiovascular Pharmacology, 1982
- Comments on "cardiotonic activity of amrinone-win 40680 [5-amino-3-4'-bypyridin-6(1H)-one]".Circulation Research, 1980
- Cardiotonic activity of amrinone--Win 40680 [5-amino-3,4'-bipyridine-6(1H)-one].Circulation Research, 1979
- Membrane formation in Tetrahymena pyriformis. 4. Lipid composition and biochemical properties of Tetrahymena pyriformis membrane systemsBiochemistry, 1971